Market closed
Precigen/$PGEN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Precigen
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Ticker
$PGEN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
202
Website
Precigen Metrics
BasicAdvanced
$559M
-
-$0.54
1.68
-
Price and volume
Market cap
$559M
Beta
1.68
52-week high
$2.17
52-week low
$0.65
Average daily volume
1.9M
Financial strength
Current ratio
1.627
Quick ratio
1.384
Long term debt to equity
8.598
Total debt to equity
10.382
Interest coverage (TTM)
-7,335.15%
Management effectiveness
Return on assets (TTM)
-43.48%
Return on equity (TTM)
-137.46%
Valuation
Price to revenue (TTM)
123.705
Price to book
10.1
Price to tangible book (TTM)
21.78
Price to free cash flow (TTM)
-5.816
Growth
Revenue change (TTM)
-41.38%
Earnings per share change (TTM)
48.67%
3-year revenue growth (CAGR)
-49.02%
3-year earnings per share growth (CAGR)
-1.28%
What the Analysts think about Precigen
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Precigen stock.
Precigen Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Precigen Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Precigen stock?
Precigen (PGEN) has a market cap of $559M as of February 25, 2025.
What is the P/E ratio for Precigen stock?
The price to earnings (P/E) ratio for Precigen (PGEN) stock is 0 as of February 25, 2025.
Does Precigen stock pay dividends?
No, Precigen (PGEN) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next Precigen dividend payment date?
Precigen (PGEN) stock does not pay dividends to its shareholders.
What is the beta indicator for Precigen?
Precigen (PGEN) has a beta rating of 1.68. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.